Recently, the Administration for Market Regulation of Sichuan Province (Intellectual Property Administration) officially announced the List of Leading Intellectual Property Enterprises in Sichuan Province for 2025. After several rounds of rigorous evaluation, Grand Shuyang was successfully included in the list due to its outstanding comprehensive strength in IPR creation, application, management, and protection, becoming one of the 14 enterprises in Chengdu to receive this recognition.

(Announcement link: http://scjgj.sc.gov.cn/scjgj/c104492/2025/8/26/5c89a99bed3643fca529a47236a1dee4.shtml)

To date, fewer than 100 enterprises in Sichuan Province have received this recognition. The "Leading Intellectual Property Enterprise in Sichuan Province" programme aims to select a group of benchmark enterprises with high-level IPR management capabilities, strong independent innovation capabilities, and significant market competitive advantages, representing the highest honor for enterprise IPR initiatives in Sichuan Province.

This designation not only signifies the government's strong recognition of Grand Shuyang's implementation of IPR strategies, construction of technological innovation systems, and application of research outcomes, but also strongly affirms the Company's industrial strength and technological competitiveness. As a key enterprise in the biomedicine field, Grand Shuyang has consistently treated IPRs as the core strategic resource for its development, integrating them comprehensively into all aspects of R&D, production, and business operations, and has established an IPR management system that covers the entire value chain.

Moving forward, Grand Shuyang will continue to strengthen its strategic IPR deployment, bolster its drive for technological innovation, and foster deep integration between IPRs and industries. This approach will further enhance the Company’s core competitiveness and industry influence, injecting strong momentum into sustained high-quality development while striving to establish a trusted Chinese brand in the life and health industry.